Your phone rings at 6 AM. A driver just tested positive. Now what?
The driver comes off the road immediately. No grace period, no "finish the load." From there, you're looking at a federally mandated return-to-duty process overseen by a Substance Abuse Professional (SAP), and you've got specific obligations at each step, from Clearinghouse reporting to SAP referral. The timeline matters.
The process begins when the MRO verifies a positive result after a CDL failed drug test under Department of Transportation (DOT) regulations, and continues through potential reinstatement.
A CDL drug test failure process begins once a verified positive drug test result is confirmed by the Medical Review Officer (MRO). This applies whether the result comes from random drug testing, post-accident testing, or any required drug screening under DOT rules.
From this point forward, the same federal process applies to all drivers who fail a drug and alcohol test — immediate removal from safety-sensitive duties, Clearinghouse reporting, SAP referral, and eventual reinstatement eligibility to drive.
The process starts when the Medical Review Officer (MRO) contacts the driver to discuss the lab result. The MRO determines whether there's a legitimate medical explanation which could include a valid prescription for an opioid. If there isn't one, the MRO verifies the result as positive and reports it to you (or your C/TPA).
The MRO verification is what triggers your obligations. A lab-positive result alone doesn't. And the clock starts the moment the MRO verifies the result.
Once you receive the verified positive result, you must immediately remove the driver from all safety-sensitive functions. Under 49 CFR §382.501, there's no grace period. The driver can't:
Same day. No exceptions. Not the next morning, not after the load delivers. Allowing a driver with a known positive to keep driving is one of the highest-penalty violations FMCSA can cite — up to $16,000 per day.
Under 49 CFR §382.705, employers (or their designated C/TPA) must report the violation to the FMCSA Drug & Alcohol Clearinghouse. The reporting deadlines are tight:
| Event | Reporting Deadline |
|---|---|
| Verified positive test result | Within 3 business days of MRO verification |
| Refusal to test | Within 3 business days |
| Actual knowledge violation | Within 3 business days |
| Return-to-duty test result (negative) | Reported by the MRO directly |
Any carrier running a pre-employment full query will see the unresolved violation. The Clearinghouse record follows the driver across employers. There is no way to quietly move past it.
Under Clearinghouse II (effective November 18, 2024), states are now required to pull the CDL privilege of any driver with an unresolved violation. This means the driver's state licensing agency (SDLA) gets notified of the violation and must downgrade the CDL to a non-CDL license until the violation is resolved. The driver can't obtain a CDL from any state while it remains unresolved.
A fundamental shift from the original rule, which relied on employers to query. Now the CDL itself is directly affected. A lot of carriers are still operating under the old assumptions.
“Clearinghouse II closed the biggest loophole in the system. Before, a driver could fail a test with one carrier and get hired the next day by a carrier that didn't run a query. Now the CDL itself is flagged at the state level.”
Foley Compliance Team, FMCSA-Registered C/TPA
You must provide the driver with a list of qualified Substance Abuse Professionals (SAPs) as defined under 49 CFR Part 40, Subpart O. Not optional. You owe this referral even if you're terminating the driver that same day.
A qualified SAP must hold one of six credentials under 49 CFR Part 40: licensed physician (MD or DO), licensed social worker or psychologist, certified employee assistance professional, licensed marriage and family therapist, or addiction counselor with DOT-specific training.
The SAP conducts a face-to-face clinical evaluation and prescribes a course of treatment or education tailored to the driver. Managing the SAP process on top of everything else is where most fleets hit a wall.
The SAP determines the required treatment, which may include outpatient counseling or education programs, inpatient treatment, or ongoing therapy sessions. Sometimes a combination.
The driver must complete all recommended treatment. No shortcuts, no waivers. Track where the driver is in this process carefully — the SAP does a follow-up evaluation to confirm the driver has complied with every recommendation before anything else moves forward.
Once the SAP confirms successful treatment completion, the driver must pass a return-to-duty drug test under direct observation. The result must be verified negative before the driver can touch a CMV again.
If it comes back positive, the whole process resets from the SAP evaluation stage. No shortcut.
After returning to duty, the driver enters a mandatory follow-up testing period:
| Follow-Up Requirement | Details |
|---|---|
| Minimum tests in Year 1 | 6 (directly observed) |
| Maximum follow-up period | 60 months |
| Who sets the schedule | The SAP |
| Can the employer modify the schedule? | No, only the original SAP can modify it |
Federal regulations don't require you to rehire or retain the driver. Your obligations are:
That's it. The employment decision is yours. Many carriers terminate after a first offense. Others, particularly those facing driver shortages, retain drivers who complete the RTD process.
But if you retain or rehire, you own the follow-up testing schedule the SAP sets, plus Clearinghouse reporting for RTD completion. Most carriers don't build that into their process until they're already behind.
Under 49 CFR Part 382, a refusal to test is treated identically to a verified positive. Same removal, same Clearinghouse report, same SAP referral. Carriers need to know what counts as a refusal because the list is longer than most people think:
The shy bladder scenario trips up a lot of carriers. If a donor can't produce a specimen within three hours, the collector reports it. The MRO then directs the donor to a physician for a medical evaluation. If there's no legitimate medical explanation, the MRO reports it as a refusal. Your drug testing program procedures need to cover this explicitly.
Supervisor training matters here more than anywhere else. If a supervisor doesn't document a refusal correctly — or doesn't recognize one — the carrier loses its ability to enforce the violation. Train your supervisors on every scenario above, and make sure your recordkeeping process captures refusals the same way it captures positives.
A second positive doesn't carry enhanced federal penalties. The same RTD process applies: SAP evaluation, treatment, return-to-duty test, follow-up testing. But the SAP has broad discretion, and most will prescribe more intensive treatment the second time around. Where a first offense might get outpatient counseling and education, a second often means inpatient treatment and a follow-up testing period that stretches toward the 60-month maximum.
From a practical standpoint, very few carriers retain a driver after a second violation. The liability math doesn't work. If that driver causes an accident, a plaintiff's attorney will pull Clearinghouse records showing two violations, and the carrier's decision to retain will be exhibit A. Your consortium should be flagging repeat violations in its reporting.
The driver's career isn't necessarily over, but it gets dramatically harder. With two unresolved violations in the Clearinghouse, most pre-employment queries will screen them out. They'll need to complete the full return-to-duty process again and find a carrier willing to take the risk — which usually means smaller operations desperate for drivers.
Drug and alcohol violations feed directly into the FMCSA's Drug & Alcohol BASIC category within the CSA scoring system. Each violation degrades your percentile ranking relative to peer carriers. Once you cross certain thresholds, FMCSA issues warning letters and may prioritize your operation for a compliance review. Multiple violations in a short window compound the damage fast.
Insurance carriers pull CSA data too. A poor Drug & Alcohol BASIC percentile is one of the quickest ways to see your premiums jump at renewal. Some insurers won't quote you at all above certain thresholds. The violation stays on your BASIC profile for three years from the date of the inspection or test, so one bad quarter can haunt your rates through multiple renewal cycles.
The Clearinghouse adds another layer of visibility. Every employer running pre-employment or annual queries sees unresolved violations tied to your drivers. If you've got drivers with open violations still on your roster, that's a red flag other carriers and auditors can see. Keeping your random testing program tight and your testing documentation clean won't prevent every positive, but it demonstrates the kind of DOT-compliant program that holds up under audit scrutiny.
The financial exposure for mishandling a positive test adds up fast:
| Failure | Consequence |
|---|---|
| Not removing the driver from duty | Up to $16,000/day per violation |
| Not reporting to Clearinghouse | Up to $5,833 per occurrence |
| Not providing SAP referral | Citable violation |
| Hiring a driver with an unresolved violation | Full liability for any accidents |
And those are just the fines. A poor compliance record hits your CSA score and insurance rates too. FMCSA audits are designed to catch exactly this.
For carriers who'd rather not deal with the operational burden of Clearinghouse reporting, SAP coordination, RTD scheduling, and follow-up test management, Foley handles it as your C/TPA — from violation through reinstatement. Request a demo to see how it works in Dash.
The employer must immediately remove the driver from all safety-sensitive functions, report the violation to the FMCSA Drug & Alcohol Clearinghouse, and provide the driver with a list of qualified Substance Abuse Professionals (SAPs). The driver cannot return to safety-sensitive duties until they complete the full return-to-duty process.
The timeline depends on the SAP's recommended treatment plan. At minimum, the driver must complete an SAP evaluation, follow prescribed education or treatment, pass a directly observed return-to-duty test, and receive SAP clearance. Straightforward cases take 2 to 3 months; cases requiring inpatient treatment take 4 to 6 months or longer.
No. A positive result does not permanently revoke a CDL, but the driver cannot perform safety-sensitive functions until they complete the SAP evaluation and return-to-duty process. Under Clearinghouse II, some states may downgrade or suspend the CDL until the violation is resolved.
No. Federal regulations require the employer to provide SAP referral information, but there is no obligation to hold the driver's position or rehire them after they complete the return-to-duty process. That is an employer-level decision.
Failure to report a drug or alcohol violation to the FMCSA Clearinghouse is itself a violation of 49 CFR Part 382, carrying fines of up to $5,833 per occurrence. It also exposes the carrier to significant liability if the driver causes an accident while employed by another carrier.
Yes. Under 49 CFR Part 382, refusal to submit to a drug or alcohol test carries the same consequences as a verified positive. This includes failure to appear, failure to provide adequate specimen, adulterated or substituted specimens, and leaving the collection site before the process is complete.
Federal regulations don't prohibit it. The driver can complete the full RTD process and return to safety-sensitive functions. Whether the employer retains or rehires is an employer-level decision, not a regulatory one.
The same RTD process applies — SAP evaluation, treatment, RTD test, follow-up testing. There's no enhanced penalty under federal regulation for repeat violations, but the SAP may prescribe more intensive treatment and a longer follow-up period (up to 60 months).
Drug and alcohol violations appear in the FMCSA's Drug & Alcohol BASIC category. Accumulating violations degrades your CSA percentile, which can trigger FMCSA interventions and increase insurance premiums.